NCT00001371View on ClinicalTrials.gov

A Pilot Study of Topical Antiflammin-2 for Psoriasis

CompletedOBSERVATIONAL

Enrollment

24

Participants

Timeline

Start Date

December 31, 1993

Study Completion Date

December 31, 2000

Conditions

Psoriasis

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH